got my ann gen meeting voting and proxy papers in the mail yesterday just picked up white paper glossy a really great summary for where we are are at and the opportunity ahead just fantastic guys, all humour aside and put to bed now while we've been in lockdown and amusing ( some not all) each other serious days weeks months ahead now Bear with me here- just for enhancing speculative pavlov appetites
... True , fact no but supposition , ? Something rare until trump goes - Big Pharma must be closely watching world bio conference lead keynote company speaker
great pre clinical results with no realistic toxicity at dosage levels way under thresholds demonstration ex vivo across the board - bacteria of any type or threat and virus killing efficacy Indeed efficacy like or better than the best even if those alternatives were available for use ( which they are not due to toxicity or now increasing failure after repeated irresponsible use) over coming months the market will realise that big pharma has no alternative new paths to pursue j an j , im sure given co exec history closely watching, the other big guys watching each other i really do expect a move of some sort in 2021 no.... no not takeover rambling speculation
the register wont lend itself to that but some very generous financing trial program / fda assistance/ licensing for distribution or in those fields combined i have now three years of continuous research on this company and have read all patent details available i have i can assure you all , back sourced and read all available publications to medical research fraternity i could sell my stuff to a research broker for a researcher salary ha ha ( petty cash these days) i have accordingly invested in backing this company for the long term future i am a proven tested and very successful investor in financial markets across all asset classes
i am very happy to retain my sense of humour and attitude to positive assistance of the downtrodden and unfairly treated retail investor class my only real objective for contributing to the hc posts repartee
RCE Price at posting:
95.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)